CAD 0.04
(-20.0%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | -59.07 Thousand CAD | -91.28% |
2022 | -30.88 Thousand CAD | -349.4% |
2021 | -6872.00 CAD | -321.6% |
2020 | -1630.00 CAD | 50.29% |
2019 | -3279.00 CAD | 49.86% |
2018 | -6540.00 CAD | -44.15% |
2017 | -4537.00 CAD | 0.0% |
2016 | - CAD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | -12.55 Thousand CAD | 15.34% |
2023 Q3 | -14.59 Thousand CAD | 3.41% |
2023 FY | -59.07 Thousand CAD | -91.28% |
2023 Q1 | -14.53 Thousand CAD | -1.25% |
2023 Q2 | -15.11 Thousand CAD | -3.97% |
2023 Q4 | -14.82 Thousand CAD | -1.55% |
2022 Q2 | -3367.00 CAD | -23.24% |
2022 Q1 | -2732.00 CAD | -14251.04% |
2022 FY | -30.88 Thousand CAD | -349.4% |
2022 Q4 | -14.35 Thousand CAD | -37.71% |
2022 Q3 | -10.42 Thousand CAD | -209.65% |
2021 Q2 | -15.01 CAD | 98.35% |
2021 Q3 | -4.30 CAD | 71.38% |
2021 Q4 | 19.31 CAD | 549.39% |
2021 FY | -6872.00 CAD | -321.6% |
2021 Q1 | -909.00 CAD | -128.97% |
2020 Q2 | -1.18 CAD | -396.2% |
2020 FY | -1630.00 CAD | 50.29% |
2020 Q4 | -397.00 CAD | -47.31% |
2020 Q3 | -269.50 CAD | -22816.5% |
2020 Q1 | -0.24 CAD | 99.56% |
2019 Q2 | - CAD | 0.0% |
2019 FY | -3279.00 CAD | 49.86% |
2019 Q4 | -54.44 CAD | -477.94% |
2019 Q1 | - CAD | 0.0% |
2019 Q3 | -9.42 CAD | 0.0% |
2018 Q2 | - CAD | 0.0% |
2018 Q3 | - CAD | 0.0% |
2018 Q4 | - CAD | 0.0% |
2018 FY | -6540.00 CAD | -44.15% |
2018 Q1 | - CAD | -100.0% |
2017 Q3 | 13.48 CAD | 106.74% |
2017 Q4 | 166.56 CAD | 1135.63% |
2017 FY | -4537.00 CAD | 0.0% |
2017 Q1 | - CAD | 0.0% |
2017 Q2 | -200.00 CAD | 0.0% |
2016 Q2 | - CAD | 0.0% |
2016 Q1 | - CAD | 0.0% |
2016 Q4 | - CAD | 0.0% |
2016 FY | - CAD | 0.0% |
2016 Q3 | - CAD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
BioMark Diagnostics Inc. | 163.22 Thousand CAD | 136.192% |
Sona Nanotech Inc. | -456.76 Thousand CAD | 87.067% |